Heghine Khachatryan: Why the EHC Fully Supports the Lancet Commission on Women’s Hematological Health
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:
“I am delighted to see this landmark Lancet Haematology Commission addressing one of the most important yet historically under-recognized areas in hematology—the health of women and girls with hematological disorders.
Congratulations to my esteemed colleague, Prof. Jecko Thachil, who led the section on Bleeding Disorders in Women.
Knowing Jecko, I am not surprised that he mentioned this remarkable achievement with such humility.
Yet, contributions like these have the potential to influence clinical practice, research priorities, and health policy for years to come.
Women with inherited and acquired bleeding disorders continue to experience delayed diagnosis, under-recognition of heavy menstrual bleeding, inequities in access to care, and an increased burden of pregnancy- and postpartum-related complications.
Bringing these issues to the forefront of global hematology is both timely and essential.
I am particularly pleased that this Commission aligns with the growing international momentum to improve care for people living with bleeding disorders.
Earlier this year, the WHO Resolution on inherited bleeding disorders, developed with the active support of Armenia and many international colleagues, reinforced the importance of equitable access to diagnosis, multidisciplinary care, and evidence-based management worldwide.
As hematologists, we have a responsibility not only to advance science but also to advocate for those whose voices have too often gone unheard.
Congratulations once again, Jecko, and to all the distinguished contributors to this outstanding Commission.
I look forward to seeing its recommendations translated into meaningful improvements in women’s hematology care across the globe.”
Panagiotis Christoforou, Senior Research Fellow at Barts Health NHS Trust, shared Heghine Khachatryan’s on LinkedIn:
“Women with bleeding disorders represent one of the most under-recognised and underserved groups in haemostasis.
Despite experiencing significant bleeding symptoms, including heavy menstrual bleeding, pregnancy-related bleeding, and excessive bleeding following procedures – many women remain undiagnosed or are diagnosed only after years of symptoms.
This long-standing disparity reflects historical misconceptions, limited awareness, and gaps in research and clinical care.
Improving recognition, diagnosis, and management of women with bleeding disorders is therefore essential to achieving equitable, patient-centred haemostasis care.
EHC – European Haemophilia Consortium fully supports this important initiative and is committed to raising awareness to ensure that no woman or girl with a bleeding disorder is left behind.”
Other posts featuring Heghine Khachatryan and Panagiotis Christoforou on Hemostasis Today.
-
Jul 8, 2026, 19:40Autoregulation Failure in SVD and Cognitive Impairment – International Journal of Stroke
-
Jul 8, 2026, 19:30Ahmed Mostafa: Why Antibodies Cause Organ Rejection
-
Jul 8, 2026, 19:28Erika Bocanegra: Witnessing 25 Years of Progress in Bleeding Disorders Care
-
Jul 8, 2026, 19:27Ahmadou Ouedraogo: Do You Know Your Blood Type?
-
Jul 8, 2026, 19:26Javed Anees: An Evidence-Based Clinical Guide to ESA Therapy
-
Jul 8, 2026, 19:25Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research
-
Jul 8, 2026, 19:25Luca Saba: Why Does the Same Patient Have Different Plaque in Different Arteries?
-
Jul 8, 2026, 19:25Luisa Weiss: Understanding the Molecular Differences Between Acute and Chronic Coronary Syndromes.
-
Jul 8, 2026, 19:11J. Meireles-Brandao: Role of Modifiable Cardiovascular Risk Factors in Dementia Development